1. Dual Inhibition of Phosphodiesterase 4 and Matrix Metalloproteinases by an (Arylsulfonyl)hydroxamic Acid Template
2. Nanomolar Inhibitors for Two Distinct Biological Target Families from a Single Synthetic Sequence: A Next Step in Combinatorial Library Design?
3. Solid-Phase Horner−Emmons Synthesis of Olefins
4. Parallel Synthesis of Aldehydes and Ketone Facilitated by a New Solid-Phase Weinreb Amide
5. The 3-O-cyclopentyl-4-O-methyl benzene moiety is a common pharmaaphcore for the rolipram class of PDE4 inhibitors. (a) Activity for RP73401 (compd 15j in the reference) inhibits PDE4 with an IC50=1 nM; Ashton, M.; Cook, D. C.; Fenton, G.; Karlsson, J.-A.; Palfreyman, M. N.; Raeburn, D.; Ratcliffe, A. J.; Souness, J. E.; Thurairatnam, S.; Vicker, N. J. Med. Chem. 1994, 37, 1696. (b) Kleinman, E. F.; Campbell, E.; Giordano, L. A.; Cohan, V. L.; Jenkinson, T. H.; Cheng, J. B.; Shirley, J. T.; Pettipher, E. R.; Salter, E. D.; Hibbs, T. A.; DiCapua, F. M.; Bordner, J. J. Med. Chem. 1998, 41, 266. (c) Newton, C.; Decicco, C. P. J. Med. Chem. 1999, 42, 2295. (d) Christensen, S.; Torphy, T. Annu. Rep. Med. Chem. 1994, 29, 185.